{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:31:13Z","timestamp":1793082673944,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.ijantimicag.2017.07.003","type":"journal-article","created":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T19:45:55Z","timestamp":1499715955000},"page":"657-663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Bloodstream infections due to extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae among patients with malignancy: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"50","author":[{"given":"Michail","family":"Alevizakos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apostolos","family":"Gaitanidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Andreatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karuppiah","family":"Arunachalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myrto Eleni","family":"Flokas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftherios","family":"Mylonakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0010","doi-asserted-by":"crossref","first-page":"e0140754","DOI":"10.1371\/journal.pone.0140754","article-title":"Clinical and molecular epidemiology of extended-spectrum \u03b2-lactamase-producing Klebsiella spp.: a systematic review and meta-analyses","volume":"10","author":"Hendrik","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0015","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2217\/fmb.12.100","article-title":"Detecting risk and predicting patient mortality in patients with extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae bloodstream infections","volume":"7","author":"Trecarichi","year":"2012","journal-title":"Future Microbiol"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/1040841X.2013.875515","article-title":"Colonization and infection with extended spectrum \u03b2-lactamase producing Enterobacteriaceae in high-risk patients\u2014review of the literature from a clinical perspective","volume":"42","author":"Biehl","year":"2016","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13756-016-0114-7","article-title":"Infections caused by extended-spectrum \u03b2-lactamases producing Enterobacteriaceae: clinical and economic impact in patients hospitalized in 2 teaching hospitals in Dakar, Senegal","volume":"5","author":"Ndir","year":"2016","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0030","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0035","series-title":"Performance standards for antimicrobial susceptibility testing","author":"Clinical and Laboratory Standards Institute","year":"2016"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0040","series-title":"EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and\/or epidemiological importance","author":"European Committee on Antimicrobial Susceptibility Testing","year":"2013"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0045","series-title":"The Newcastle\u2013Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells","year":"2000"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0050","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0055","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jinf.2016.07.014","article-title":"Prevalence of ESBL-producing Enterobacteriaceae in paediatric urinary tract infections: a systematic review and meta-analysis","volume":"73","author":"Flokas","year":"2016","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0060","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.ijantimicag.2016.08.021","article-title":"Colonisation with extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae and risk for infection among patients with solid or haematological malignancy: a systematic review and meta-analysis","volume":"48","author":"Alevizakos","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0065","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/sj.bmt.1705677","article-title":"Epidemiology of bacteremia and factors associated with multi-drug-resistant Gram-negative bacteremia in hematopoietic stem cell transplant recipients","volume":"39","author":"Oliveira","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0070","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jiph.2015.11.004","article-title":"A de-escalation protocol for febrile neutropenia cases and its impact on carbapenem resistance: a retrospective, quasi-experimental single-center study","volume":"9","author":"Alshukairi","year":"2016","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0075","first-page":"15","article-title":"Patterns of bacteremia in cancer patient with febrile neutropenia at King Abdullah University Hospital\u2014Jordan 2003\u20132008","volume":"7","author":"Al-Sweedan","year":"2012","journal-title":"J Pediatr Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0080","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jgo.2012.10.174","article-title":"Health-care associated bacteremia in geriatric cancer patients with febrile neutropenia","volume":"4","author":"Aydemir","year":"2013","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0085","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00520-013-2012-3","article-title":"Epidemiology, antibiotic therapy and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in cancer patients","volume":"22","author":"Bodro","year":"2014","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0090","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00277-013-1965-0","article-title":"Relapsing bloodstream infections during treatment of acute leukemia","volume":"93","author":"Cattaneo","year":"2014","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0095","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1186\/1471-2334-13-563","article-title":"Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis","volume":"13","author":"De Rosa","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0100","first-page":"362","article-title":"The outcome of non-carbapenem-based empirical antibacterial therapy and VRE colonisation in patients with hematological malignancies","volume":"13","author":"Gedik","year":"2013","journal-title":"Afr Health Sci"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0105","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3109\/23744235.2016.1143963","article-title":"Ciprofloxacin prophylaxis delays initiation of broad-spectrum antibiotic therapy and reduces the overall use of antimicrobial agents during induction therapy for acute leukaemia: a single-centre study","volume":"48","author":"Hallb\u00f6\u00f6k","year":"2016","journal-title":"Infect Dis (Lond)"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0110","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3109\/23744235.2015.1051105","article-title":"Epidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies","volume":"47","author":"Kara","year":"2015","journal-title":"Infect Dis (Lond)"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0115","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1055\/s-0031-1287838","article-title":"Bloodstream infections in paediatric cancer patients. Prospective comparative study in 2 university hospitals","volume":"223","author":"Krenn","year":"2011","journal-title":"Klin Padiatr"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0120","doi-asserted-by":"crossref","first-page":"216","DOI":"10.4274\/tjh.2014.0378","article-title":"The changing epidemiology of bloodstream infections and resistance in hematopoietic stem cell transplantation recipients","volume":"33","author":"Yemisen","year":"2016","journal-title":"Turk J Haematol"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0125","doi-asserted-by":"crossref","first-page":"415","DOI":"10.4103\/0019-509X.175365","article-title":"Microbiology, infection control and infection related outcome in pediatric patients in an oncology center in Eastern India: experience from Tata Medical Center, Kolkata","volume":"51","author":"Bhattacharyya","year":"2014","journal-title":"Indian J Cancer"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0130","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4103\/0019-509X.175363","article-title":"Review of spectrum and sensitivity of bacterial bloodstream isolates in children with malignancy: a retrospective analysis from a single center","volume":"51","author":"Reddy","year":"2014","journal-title":"Indian J Cancer"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0135","doi-asserted-by":"crossref","first-page":"403","DOI":"10.4103\/0019-509X.175367","article-title":"Spectrum of systemic bacterial infections during febrile neutropenia in pediatric oncology patients in tertiary care pediatric center","volume":"51","author":"Siddaiahgari","year":"2014","journal-title":"Indian J Cancer"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0140","first-page":"439","article-title":"Emergence of multidrug resistant Acinetobacter blood stream infections in febrile neutropenia patients with haematological cancers and bone marrow failure syndromes","volume":"110","author":"Sood","year":"2012","journal-title":"J Indian Med Assoc"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0145","first-page":"10","article-title":"Improving the emergency department management of post-chemotherapy sepsis in haematological malignancy patients","volume":"21","author":"Ko","year":"2015","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0150","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3947\/ic.2013.45.1.51","article-title":"Epidemiology and clinical features of bloodstream infections in hematology wards: one year experience at the Catholic Blood and Marrow Transplantation Center","volume":"45","author":"Kwon","year":"2013","journal-title":"Infect Chemother"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0155","first-page":"83","article-title":"Risk assessment and microbiological profile of infections in paediatric cancer patients with febrile neutropenia","volume":"24","author":"Latiff","year":"2002","journal-title":"Malays J Pathol"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0160","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s11845-013-1043-6","article-title":"Risk factors for hospital-acquired bloodstream infections caused by extended-spectrum \u03b2-lactamase Klebsiella pneumoniae among cancer patients","volume":"183","author":"Li","year":"2014","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0165","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijid.2016.01.006","article-title":"Differences in characteristics between first and breakthrough neutropenic fever after chemotherapy in patients with hematologic disease","volume":"44","author":"Nam","year":"2016","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0170","doi-asserted-by":"crossref","first-page":"e186","DOI":"10.1097\/MPH.0b013e31821ba92c","article-title":"Etiology of septicemia in children with acute leukemia: 9-year experience from a children's hospital in China","volume":"33","author":"Ye","year":"2011","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0175","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/jac\/dkp411","article-title":"Bacteraemia due to extended-spectrum \u03b2-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome","volume":"65","author":"Gudiol","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0180","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/bjh.13113","article-title":"Mucosal barrier injury, fever and infection in neutropenic patients with cancer: introducing the paradigm febrile mucositis","volume":"167","author":"van der Velden","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0185","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00277-011-1247-7","article-title":"Risk factors for infection and treatment outcome of extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy","volume":"91","author":"Kang","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0190","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1128\/AAC.00143-10","article-title":"Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-\u03b2-lactamase production and inadequate initial antibiotic therapy","volume":"54","author":"Tumbarello","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0195","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ijantimicag.2013.07.018","article-title":"Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum \u03b2-lactamase-producing Escherichia coli in patients with cancer","volume":"42","author":"Ha","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0200","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0140-6736(15)00473-0","article-title":"Understanding the mechanisms and drivers of antimicrobial resistance","volume":"387","author":"Holmes","year":"2016","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2017.07.003_bib0205","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1469-0691.2007.01855.x","article-title":"Prevalence and clonality of extended-spectrum \u03b2-lactamases in Asia","volume":"14","author":"Hawkey","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0210","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","article-title":"Extended-spectrum \u03b2-lactamases: a clinical update","volume":"18","author":"Paterson","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0215","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1179\/joc.2011.23.6.341","article-title":"Impact of ceftriaxone de-restriction on the occurrence of ESBL-positive bacterial strains and antibiotic consumption","volume":"23","author":"Skrlin","year":"2011","journal-title":"J Chemother"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0220","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s40121-015-0081-y","article-title":"Considerations about antimicrobial stewardship in settings with epidemic extended-spectrum \u03b2-lactamase-producing or carbapenem-resistant Enterobacteriaceae","volume":"4","author":"Viale","year":"2015","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0225","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/1471-2334-14-286","article-title":"Association between adherence to an antimicrobial stewardship program and mortality among hospitalised cancer patients with febrile neutropaenia: a prospective cohort study","volume":"14","author":"Rosa","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.07.003_bib0230","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/cid\/cis770","article-title":"Rate of transmission of extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae without contact isolation","volume":"55","author":"Tschudin-Sutter","year":"2012","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917302765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917302765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,29]],"date-time":"2019-09-29T09:48:50Z","timestamp":1569750530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857917302765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0924857917302765"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.07.003","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bloodstream infections due to extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae among patients with malignancy: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}